MedTrace Logo

Efficacy of a Dietary Ingredient Combination With Omega-3 for Joint Function

NCT05279573 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2022-12-28

No results posted yet for this study

Summary

Randomized, controlled, double-blind intervention study of four parallel branches depending on the product consumed, to analyze the efficacy of an Omega-3 based product on the mobility and functionality of the evaluated joint.

Conditions

  • Joint Function Disorder

Interventions

DIETARY_SUPPLEMENT

Omega-3 and/or botanical ingredient

Consumption for 60 days. Subjects should consume two capsules in the morning and two capsules in the afternoon.

OTHER

Control product consumption

Product with identical characteristics to the experimental product. Consumption for 60 days. Subjects should consume two capsules in the morning and two capsules in the afternoon.

Sponsors & Collaborators

  • Evonik Operations GmbH

    collaborator UNKNOWN

  • Universidad Católica San Antonio de Murcia

    lead OTHER

Principal Investigators

  • Fco Javier López Roman · Catholic University of Murcia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-14
Primary Completion
2022-11-29
Completion
2022-12-23

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05279573 on ClinicalTrials.gov